Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) On
Item 7.01. Regulation FD Disclosure.
A copy of the press release, dated
The information in this Item 7.01, including the exhibit hereto, shall not be
deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of that Section 11
and 12(a)(2) of the Securities Act of 1933, as amended. The information
contained herein and in the accompanying exhibit shall not be incorporated by
reference into any filing with the
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit Description 99.1 Press Release, datedOctober 4, 2021 , titled "Annexon Biosciences Further Strengthens its Executive Leadership Team with Appointment ofTed Yednock , Ph.D., to Chief Innovation Officer and Appointment of Larry Mattheakis, Ph.D., as Chief Scientific Officer" 104.1 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source